Top U.S. Marijuana Stocks to Watch in February 2026The U.S. cannabis sector enters February 2026 in a period of transition. After years of volatility, the industry is becoming more disciplined. Many operators are now prioritizing profitability instead of rapid expansion. As a result, stronger companies are beginning to separate from weaker competitors.Meanwhile, state-level legalization continues expanding across the country. Existing markets are also becoming more efficient and competitive. Consumer demand ...

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1] - The company is a leading international provider of consumer cannabis products, emphasizing quality, expertise, and reliability [3] Financial Reporting - The earnings conference call will take place on February 26, 2026, at 5:00 p.m. ET, featuring prepared remarks and a Q&A session [2] - A dial-in replay of the conference call will be available until March 5, 2026, for those unable to attend live [2] Company Overview - Curaleaf operates under various brands, including Curaleaf, Select, Grassroots, and others, providing a wide range of products in both medical and adult-use markets [3] - Curaleaf International is noted as the largest vertically integrated cannabis company in Europe, with a strong supply and distribution network [3]

Core Viewpoint - Curaleaf Holdings, Inc. plans to seek shareholder approval for a proposed arrangement to continue its operations from British Columbia, Canada to Delaware, United States, which is expected to enhance its strategic objectives and streamline its organizational structure [1][2]. Group 1: Proposed Arrangement - The proposed arrangement includes the continuation of Curaleaf from British Columbia to Delaware, with all existing subordinate voting shares being converted to Delaware subordinate voting shares [2]. - The arrangement will not result in any material changes to the Company's business or operations [3]. Group 2: Shareholder Approval Process - Curaleaf intends to send a management information circular to shareholders and hold a special meeting on or about February 23, 2026, to seek approval for the arrangement [4]. - Approval requires a two-thirds majority (66 2/3%) of the votes cast by holders of subordinate voting shares and multiple voting shares [5]. Group 3: Implementation and Future Steps - The board of directors will determine the timing for implementing the arrangement, subject to necessary approvals, and may choose not to proceed if it is not in the best interests of the Company [6]. - After the arrangement, the Delaware subordinate voting shares are expected to continue trading on the Toronto Stock Exchange and OTCQX under the same trading symbols [7].

Core Insights - Curaleaf Holdings, Inc. has secured a significant $100 million revolving credit facility, marking the largest of its kind in the U.S. cannabis sector to date [1][2] - This financing is a pivotal advancement for institutional lending within the cannabis industry, indicating growing confidence from lenders in the sector's future [1][2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the cannabis plant [3] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, and has a strong presence across the medical and adult-use markets [3] Financial Details - The newly amended credit facility has an initial term of one year, with an interest rate of 7.99% on outstanding principal, which can extend up to five years with a potential rate increase to 8.99% if the company refinances its Senior Note Facility due in 2026 [2] - Curaleaf plans to utilize at least $50 million from this credit facility to pay down higher interest-bearing acquisition-related debt while ensuring sufficient capacity for working capital needs [2]

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for the third quarter ended September 30, 2025, after market close on November 5, 2025 [1] - A conference call and audio webcast will be held on the same day at 5:00 p.m. ET to discuss the Company's operational and financial highlights [2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the plant [3] - The Company is recognized for its high growth, quality, expertise, and reliability, offering a wide range of products and services across medical and adult-use markets [3] - Curaleaf operates a strong distribution network in Europe, Canada, and Australasia, integrating science and research with advanced cultivation, extraction, and production techniques [3]